Kobayashi Pharmaceutical, the firm that was at the center of a supplement contamination scandal involving suspected deaths, is said to be considering a potential buyout offer of more than ¥500 billion. https://www.japantimes.co.jp/business/2026/09/24/kobayashi-buyout-talks/?utm_medium=Social&utm_source=mastodon #business #stocks #acquisitions #kobayashipharmaceutical #pharmaceuticals #oasismanagement #medicine
kobayashipharmaceutical
https://www.europesays.com/3272285/ Kobayashi in ¥500 billion buyout talks after red-yeast case #acquisitions #CorporateGovernance #KobayashiPharmaceutical #medicine #OasisManagement #Pharmaceuticals #Scandal #ScandalNews #stocks
